Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS JPWA, NPhA Agree to 6-Month Limit on Price Negotiations; Wholesalers’ Resolution to Be Tested for 3rd Time
April 19, 2012
-
REGULATORY Risk Management Plans to Be Required from April 2013 to Strengthen Post-Marketing Safety Measures
April 18, 2012
-
BUSINESS Eli Lilly Japan Pinning New Hopes on Solanezumab; Will the Introduction of Medicoeconomic Assessments Help?
April 18, 2012
-
BUSINESS Generic Names Used in 25% of Prescriptions Issued by GPs: Nihon Chouzai
April 17, 2012
-
BUSINESS Over 60% of Drug Makers Increased Hiring of New Graduates in 2012: Jiho Survey
April 16, 2012
-
BUSINESS Takeda to Acquire URL Pharma, Boost US Business Base Through Field of Gout
April 13, 2012
-
REGULATORY CSIMC Expert Subcommittee to Begin Discussion on Long-Listed Drugs in June, Also Deliberate on Targets for Generic Products
April 13, 2012
-
BUSINESS Pfizer Focuses on Personalized Medicine for Oncology Area with Xalkori
April 12, 2012
-
BUSINESS Sanofi Pasteur Targets Double Sales in Japan, Enters 4 Products Including IPV
April 11, 2012
-
REGULATORY PMDA to Establish Forum for Discussions Between Reviewers and Outside Researchers to Upgrade Its Ability to Review Cutting-Edge Drugs
April 10, 2012
-
BUSINESS Generics Made in India to Storm Japanese Market with Overwhelming Price Advantage
April 10, 2012
-
ACADEMIA Generic Name Prescriptions Rapidly Rise on New Premium, Tokyo Pharmaceutical Association Issues Warning
April 9, 2012
-
BUSINESS MTPC Complements Alliance with BIKEN to Establish Its Own Vaccine Development Infrastructure
April 6, 2012
-
REGULATORY MHLW to Issue 80 Requests for Development of Unapproved Drugs/Indications This Week
April 5, 2012
-
BUSINESS Mochida Aims for Sales of Over 100 Billion Yen in FY2014: New Midterm Management Plan
April 4, 2012
-
REGULATORY PMDA Strengthens Consultation System to Support Biomarker Development
April 3, 2012
-
REGULATORY DPJ’s PAL Subcommittee to Hold Off Final Recommendation on PAL Amendment Until Late April
April 2, 2012
-
REGULATORY MHLW Proposes Pricing of Long-Listed Products to Be Concluded in FY2013: CSIMC Meeting
March 30, 2012
-
BUSINESS Fujifilm, Kyowa Hakko Kirin Establish JV to Develop Biosimilars
March 29, 2012
-
BUSINESS Astellas to Place Greater Importance on China Business: Executive Katayanagi
March 28, 2012
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…